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Abstract
Here we describe a novelmethod for imaging apoptosis
in cells using a near-infrared fluorescent (NIRF) probe
selective for caspase-1 (interleukin 1–converting
enzyme, ICE). This biocompatible, optically quenched
ICE-NIRF probe incorporates a peptide substrate,
which can be selectively cleaved by caspase-1, result-
ing in the release of fluorescence signal. The specificity
of this probe for caspase-1 is supported by various
lines of evidence: 1) activation by purified caspase-1,
but not another caspase in vitro; 2) activation of the
probe by infection of cells with a herpes simplex virus
amplicon vector (HGC-ICE-lacZ) expressing a catalyti-
cally active caspase-1–lacZ fusion protein; 3) inhibition
of HGC-ICE-lacZ vector– induced activation of the
probe by coincubation with the caspase-1 inhibitor
YVAD-cmk, but not with a caspase-3 inhibitor; and
4) activation of the probe following standard methods
of inducing apoptosis with staurosporine, ganciclovir,
or ionizing radiation in culture. These results indicate
that this novel ICE-NIRF probe can be used in monitor-
ing endogenous and vector-expressed caspase-1 ac-
tivity in cells. Furthermore, tumor implant experiments
indicate that this ICE-NIRF probe can be used to de-
tect caspase-1 activity in living animals. This novel
ICE-NIRF probe should prove useful in monitoring
endogenous and vector-expressed caspase-1 activity,
and potentially apoptosis in cell culture and in vivo.
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Introduction
The balance and coordination between cell proliferation and
programmed death (apoptosis) is essential for normal
physiology. Apoptosis is involved in embryonic develop-
ment, immune cell processes, and tissue homeostasis. In
addition, neurodegenerative disorders, acquired immuno-
deficiency syndrome, cancer, myelodysplastic syndromes,
ischemia/reperfusion injury, and autoimmune disorders all
involve inappropriate apoptosis [1]. The transformation of a
normal cell to an apoptotic cell is typically characterized by loss
of cell volume, plasma membrane blebbing, nuclear chromatin
condensation and aggregation, and endonucleocytic degra-
dation of DNA into nucleosomal fragments [2]. These cell
changes occur following sequential activation of initiator and
effector caspases [3–6]. Once activated, caspases, of which
there are at least 14 different mammalian members [7–9],
cleave a variety of structural, regulatory, and DNA repair pro-
teins and, by doing so, disrupt important cellular processes
and trigger cellular and morphological events associated with
cell death [10]. Consequently, caspases are considered both
initiators and executioners of apoptosis.
The role that caspases play in immune response and
apoptosis is still being elucidated. Caspase-1, also known as
interleukin 1b–converting enzyme (ICE), was originally char-
acterized as cleaving inactive prointerleukin 1b to generate
the active proinflammatory cytokine interleukin 1b and is con-
sidered an initiator caspase [11]. Studies suggest that the
activation of caspase-1 is under the control of caspase-11
[12] and that caspase-11, in turn, is involved in caspase-3
activation and apoptosis induced by brain ischemia [13,14].
Caspase-1 is required for apoptosis in Rat-1 fibroblasts as well
as other mammalian and insect cells [11,15–17]. Caspase-1
activation is also required for human prostate cancer cells to
undergo apoptosis in response to transforming growth factor-b
[18], and the majority of primary prostate cancer specimens
(80%) have downregulation of caspase-1 expression, implicat-
ing this loss as a potential step in malignant progression [19].
Furthermore, studies have demonstrated the activation of
caspase-1 in dying motor neurons in a mouse model of
Cu2+,Zn2+ superoxide dismutase–mediated familial amyotro-
phic lateral sclerosis [20].
Visualization of cellular apoptosis has traditionally used
several approaches, including labeling with annexin V [21]
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and terminal transferase-mediated dUTP nick end labeling
(TUNEL) staining [22–24]. For both annexin V and TUNEL
staining, cells or tissues must be removed from the animal
and fixed, which may inadvertently cause cellular disrup-
tion. Examination of the specificity and sensitivity of
TUNEL staining reveals a serious drawback in its inability
to discriminate apoptotic from necrotic cells because ne-
crotic cells also have free DNA ends after oxidative and
toxic injury [25,26].
Technology to monitor apoptosis and activity of specific
caspases in living cells is currently under development.
Studies have shown that apoptosis can be noninvasively
imaged in living cells in real time using a recombinant
luciferase reporter molecule that has attenuated levels of
activity when expressed in mammalian cells [27]. This re-
porter molecule is cleaved by caspase-3 in apoptotic cells,
resulting in restoration of luciferase activity, which can be
detected in living animals with bioluminescence imaging. In
a complementary approach, we have investigated a method
to image apoptosis noninvasively and dynamically over time
using a near-infrared fluorescent (NIRF) probe activated by
caspase-1. In previous studies, we have developed a series
of novel activatable NIRF probes specific for various proteo-
lytic enzymes, such as cathepsins [28,29], matrix metal-
loproteinases [30–33], and viral proteases [34]. This novel
optical imaging technology has been used for detection of
specific protease activities in vitro, in culture, and in vivo [35].
Here we examined the specificity of a newly developed ICE-
NIRF imaging probe with purified enzymes and inhibitors
in vitro. This probe was also used to monitor caspase-1
expression in association with apoptosis resulting from
drugs, irradiation, or infection of cells with a herpes simplex
virus (HSV) amplicon vector expressing caspase-1– lacZ in
culture and from vector-infected tumor cells in vivo.
Materials and Methods
Generation of HSV Amplicons
The caspase-1– lacZ cassette (4.2 kb) was obtained from
Dr. Jungying Yuan (Harvard Medical School, Boston, MA)
[15] and cloned into the multiple cloning site (MCS) of the
HSV amplicon plasmid, pHGCX [36], which contains an HSV
origin of replication (oris), a cleavage/packaging signal (pac),
and an expression cassette for enhanced green fluorescent
protein (EGFP; Clontech, Palo Alto, CA) under an interme-
diate early viral promoter, IE4/5 (Figure 2A). The resulting
amplicon, termed HGC-ICE-lacZ, was transformed into
DH10B-competent cells and DNA from colonies was
assessed by restriction digestions. The control amplicons
were pHGCX and a version of pHGCX bearing coding
sequences for firefly luciferase in the MCS, termed pHGC-
Fluc [34].
Cell Culture
The C6BVIK cell line expressing HSV-1 thymidine kinase
(TK) was derived from the rat glioma line C6 [37] by
Ezzeddine et al. [38]. The human glioma cell line Gli36 was
originally obtained from Dr. Anthony Capagnoni (UCLA
School of Medicine, Los Angeles, CA). 2-2 cells, Vero-
derived cells that constitutively express the HSV-1 ICP27
protein, were kindly provided by Dr. Rozanne Sandri-Goldin
(UC Irvine, Irvine, CA) [39]. All cell lines were cultivated in
Dulbecco’s modified Eagle’s medium (DMEM; GIBCO,
Carlsbad, CA) containing 100U/ml penicillin, 100 mg/ml strep-
tomycin (P/S), and 10% fetal bovine serum (FBS; D10P/S)
with 500 mg/ml G418 (Geneticin; GIBCO, Carlsbad, CA).
Packaging of Amplicon DNA Into HSV-1 Virions and
Titration of Vector Stocks
Vero 2-2 cells were cotransfected with pHGC-ICE-lacZ or
pHGC-Fluc, fHSVDpacD27 0+, and pEBH-ICP27 DNA using
LipofectAMINE (GIBCO), as described [36]. After 3 days, the
cells were scraped into the medium, the suspension was
frozen and thawed three times, and cell debris was removed
by centrifugation (10 minutes, 1400  g). To concentrate the
vector stocks, the supernatant was centrifuged for 2.5 hours
at 100,000  g through a 25% sucrose solution in phos-
phate-buffered saline (PBS), pH 7.4. The pellet was sus-
pended in DMEM containing P/S, 10% FBS, and G418. To
determine vector titers [transducing units (tu) per milliliter],
293 cells were infected and, 24 hours later, green fluorescent
cells were counted under 488-nm excitation on a Zeiss
microscope (Thornwood, NY).
Synthesis of Probe
The NIRF probe was prepared following a previously
published protocol [28]. Briefly, a caspase-1–cleavable pep-
tide substrate [Gly-Trp-Glu-His-Asp-Gly-Lys fluorescein iso-
thiocyanate (FITC)-Cys-NH2] [40] that contains an N-terminal
NIRfluorochrome,Cy5.5(absorptionmaximum675nm,emis-
sion maximum 694 nm; Amersham-Pharmacia, Piscataway,
NJ), was attached to a biocompatible, partially pegylated
poly-L-lysine delivery vehicle through the C-terminal cysteine
residue to generate the ICE-NIRF probe (Figure 1A). On
average, each delivery molecule contained 18 reporter
probes with efficient autoquenching of fluorescence.
In Vitro Activation with Purified Caspases
Specific activation of the ICE-NIRF probewas tested in the
presence of purified caspase-1 or caspase-3 in PBS buffer.
The probe (0.2 mM, 500 ml) was incubated with or without
specific caspase (0.25 mg; Calbiochem, San Diego, CA) at
room temperature for 30minutes. NIRF signal wasmeasured
using a fluorescence spectrophotometer (U4500; Hitachi,
Chula Vista, CA). The excitation and emission wavelengths
were set at 675 and 694 nm, respectively. In an inhibition
experiment, a caspase-1 specific inhibitor, Ac-Tyr-Val-Ala-
Asp-CHO (4 mM; Calbiochem), was added to the caspase-1
ICE-NIRF probe mixture and studied under the same
conditions.
Assessment of Apoptosis by NIRF Probe and Annexin,
Propidium Iodide (PI), and TUNEL Staining
First, cells were treated with 1 mM ICE-NIRF probe
diluted in OptiMEM and incubated for 30 minutes in a
5% CO2 incubator. Then cells were rinsed twice with PBS
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and resuspended in 1  binding buffer (Apoptosis Kit;
Clontech) with 0.5 mg/ml annexin V–FITC and, in some
cases, 1.25 mg/ml PI per well using the annexin V–FITC
Apoptosis Kit (Clontech) and incubated for 5 to 15
minutes in the dark. Following rinsing with OptiMEM, cells
were fixed with 2% paraformaldehyde (PFA) for 15
minutes, washed with PBS twice, and mounted using Fluoro-
mount G media (Southern Biotechnology, Birmingham, AL).
The slides were observed under the confocal microscope
(Zeiss Axiovert 200) using the 633-nm laser to detect the
NIRF probe, the 488-nm laser to detect EGFP and annexin,
and the 543-nm laser to detect PI staining. Assessment of
apoptosis was also performed using TUNEL staining [41]
and detected with the 543-nm laser. The LSM 5 Pascal
Software (v. 2.8 WS) was used for quantitative analysis of
images. The ‘‘Profile’’ function of this software package was
used to compute the intensity as a function of distance along
a line drawn directly through each image. The intensities
were averaged, and the average with the 63-nm laser was
normalized to the average with the 488-nm laser.
Figure 1. Characteristics of ICE-NIRF probe. (A) Schematic diagram of the ICE-NIRF probe. In its intact state (left), the high local density of fluorochromes causes
substantial fluorescence quenching. The enzymatic activation by caspase-1, involving cleavage of the peptide substrate, results in release of the near-infrared
fluorochrome, Cy5.5 (right). (B) Specificity of ICE-NIRF probe using purified caspases. In vitro testing of this caspase-1 NIRF probe indicates that activation is
specific to caspase-1. Incubation with purified caspase-1 activated the probe 78-fold, whereas incubation of caspase-3 did not activate the probe. Furthermore,
activation of the probe by caspase-1 was blocked by coincubation with a caspase-1 inhibitor.
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Drug Treatment
In order to evaluate the specificity of the ICE-NIRF
probe, we examined the effects of the caspase-1 inhibitor,
YVAD-cmk (Clontech), and the caspase-3 inhibitor,
DEVD-fmk (Clontech), on HGC-ICE-lacZ vector– induced
probe activation. For these experiments, Gli36 cells were
plated at a density of 3  105 cells/well in 24-well plates
(BectonDickinson, Franklin Lakes, NJ), and infected 24 hours
later with either HGC-ICE-lacZ or HGC-Fluc vector. Vectors
were used at a multiplicity of infection (MOI) = 1 tu/cell, at
which over 90% of cells were infected as assessed by EGFP
fluorescence. For the caspase-1 inhibitor, 24 hours after
being plated, cells were coincubated with 25 mM YVAD-cmk
andHGC-ICE-lacZ vector (MOI = 1) for 24 hours. For the cas-
pase-3 inhibitor, a parallel experiment was carried out using
10 mM DEVD-fmk. To evaluate caspase-1 activity and apop-
tosis, cells were assessed for NIRF probe activation and an-
nexin andTUNELstaining, as above. Tetrazoliumsalt WST-1
cell viability assays were performed to confirm that these
inhibitors were not toxic to Gli36 cells under these conditions.
To induce apoptosis, Gli36 cells were exposed to 50 mM
staurosporine (Sigma, St. Louis, MO) for 24 hours, then
washed twice in PBS and evaluated for ICE-NIRF probe
fluorescence and annexin staining. Control cells were ex-
posed to 0.01% DMSO, the same percentage as in the
staurosporine-treated cells.
Based on cell viability experiments, 100 mg/ml ganciclovir
(Cytovene-IV; Roche Laboratories, Nutley, NJ), which gave
69% viability of C6VIK cells after 7 days of exposure, was used
for culture experiments. C6VIK cells were plated at 1  105 per
well in a 24-well plate. Twenty-four hours after plating, gan-
ciclovir (100 mg/ml) was applied for time points ranging from1 to
7 days. Fresh ganciclovir was added to media every other day.
At each time point, media and drug were removed, cells
washed twice with PBS, ICE-NIRF probe, and annexin were
applied, and then TUNEL staining was carried out and the
slides were evaluated 24 hours later by confocal microscopy.
Cell Viability Assays
Viability was assessed with the cell proliferation reagent,
WST-1 (Roche Molecular Biochemicals, Penzberg, Ger-
many), for Gli36 cells treated with the caspase-3 inhibitor
and for C6VIK cells treated with ganciclovir. One thousand
cells per well were plated in a 96-well plastic plate and,
24 hours later, the drug was added at the following concen-
trations: 5, 10, and 25 mM for DEVD-fmk and 50, 100, and
150 mg/ml for ganciclovir. Cells were exposed to the drug for
24 hours or 7 days, respectively, at which time media was
aspirated and cells were incubated in 100 ml of fresh media
and 10 ml of WST-1 reagent for 4 hours at 37jC in a 5% CO2
incubator. Readings were taken on a Spectra max Plus
384 spectrophotometer (Molecular Devices Corporation) at
420 nm wavelength, and data were analyzed using Prism
3.03. Drug concentrations were tested in triplicate.
Granule Cell Preparation
Cultures enriched in granule neurons were prepared from
dissociated cerebella of 5-day–old mice (129Sv/C57B6
mixed background), as described [42]. One day after cultur-
ing, the antimitotic drug, cytosine-D-arabinofuranoside
(10 mM), was added to prevent proliferation of non-neuronal
cells. After 3 days in culture, cells were irradiated with 14 Gy
delivered from a 137Cs source at 5.37 Gy/min. Twenty-four
hours after irradiation, cells were incubated with the NIRF
probe and annexin, as described above.
In Vivo NIRF Imaging
In an experimental in vivo implant model, Gli36 cells were
infected in culture with HGCX-ICE-lacZ or HGCX vector at
an MOI = 1.0. Four hours postinfection, cells were trypsi-
nized, collected by centrifugation at 3000  g for 5 minutes,
and washed twice in PBS; and the 4  106 cells resus-
pended in 50 ml of PBS, mixed with 50 ml growth media, and
then injected subcutaneously bilaterally under the fore-
arms of five nude mice. Anesthesized mice were imaged
24 hours following intravenous (i.v.) probe administration
of the ICE-NIRF probe (2 nmol of ICE-NIRF probe per ani-
mal) using a whole-body NIRF imaging system (CMIR,
Charlestown, MA).
The imaging system consisted of a light-tight box equip-
ped with a 150-W halogen lamp and an excitation filter
system for Cy5.5 (610–650 nm; Omega Optical, Brattler-
buro, VT). The field of view was homogenous to ± 10% over
a 5  5-cm area through the use of fiberoptic cables and
beam diffusers. Fluorescence was detected by a 12-bit
monochrome CCD camera (Photometrics, Tuscon, AZ;
Kodak, Rochester, NY) equipped with a C-mount lens and
an emission filter at 700 nm (Omega Optical). Images were
digitally acquired as 16-bit Tiff files and processed on a
Macintosh computer using commercially available software
(IP Lab Spectrum; Signal Analytics, Vienna, VA) [29]. Bright-
field and NIRF images were collected and images super-
imposed. Quantification of fluorescence was done using
CMIR image program by finding the mean pixel intensity of
each implant infected with HGC-ICE or HGCX, as well as the
background fluorescence from an adjacent region in each
mouse.
Statistical Analysis
Statistical analysis was conducted using Microsoft Excel
97 SR-2. For cell culture experiments, a two-sample t-test
assuming equal variances was conducted by comparing the
average intensity of the probe signal across the microscopic
field at 633 nm normalized to the average intensity of the
EGFP signal at 488 nm between groups. For in vivo experi-
ments, statistical analysis comparing the mean pixel inten-
sities between treatment groups was conducted using a
t-test: paired two sample for means, which gave a P (T < t )
one-tail value.
Results
Specificity of NIRF Probe for Caspase-1
The specificity of the ICE-NIRF probe for caspase-1
(Figure 1A) was evaluated in two ways: 1) incubation of the
probe with purified caspase-1 or caspase-3 in vitro; and 2)
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incubation of HGC-ICE-lacZ vector– infected cells in culture
with the probe in the presence of a caspase-1 inhibitor or a
caspase-3 inhibitor. For in vitro testing, the probe was
incubated with or without purified caspase-1 or caspase-3
over 30 minutes at room temperature. Incubation of the
probe with purified caspase-1 resulted in a 78-fold increase
in fluorescence (Figure 1B). Activation of the probe by
caspase-1 was blocked over 95% by coincubation with a
caspase-1–specific inhibitor. In comparison, the incubation
of the probe with purified caspase-3 caused no changes in
fluorescence signal.
In order to deliver the caspase-1– lacZ fusion protein to
cells, coding sequences were placed under the CMV pro-
moter in an amplicon plasmid, pHGCX [35], yielding pHGC-
ICE-lacZ (Figure 2A). For convenient monitoring of gene
expression, this construct includes a reporter EGFP cassette
under an immediate early viral promoter (IE4/5). A parallel
amplicon construct containing luciferase under the CMV
promoter, pHGC-Fluc, was used as a control vector.
Gli36 cells were infected with packaged HGC-ICE-lacZ or
control vector at an MOI = 1. Twenty-four hours following
infection, cells evaluated for ICE-NIRF probe fluorescence
indicated a specific signal in HGC-ICE-lacZ vector– infected
cells (Figure 2D). Infection of Gli36 cells with the HGC-ICE-
lacZ vector also induced apoptosis indicated by positive
TUNEL staining (Figure 2C) concomitant with activation of
the ICE-NIRF probe. Both apoptosis and probe activation
were substantially blocked by incubation of cells infected
with the HGC-ICE-lacZ vector with the caspase-1 inhibi-
tor, YVAD-cmk, indicating specificity for caspase-1 (Figure 2,
F and G). Infection of Gli36 cells with the control vector,
HGC-Fluc, did not induce apoptosis, indicated by the
Figure 2. HSV amplicon vector expressing caspase-1– lacZ induces apoptosis and activates ICE-NIRF probe. (A) pHGC-ICE-lacZ amplicon. ICE– lacZ cDNA was
cloned into the multicloning site of the HSV amplicon pHGCX under the control of a CMV promoter. The pHGCX backbone contains an HSV origin of replication
(oris), a cleavage/packaging signal (pac), as well as EGFP, under an intermediate early viral promoter, IE4/5 [36]. Infection of Gli36 with the HGC-ICE-lacZ vector
(B and E; EGFP fluorescence) induces apoptosis, indicated by positive TUNEL staining (C) and activation of the caspase-1 NIRF probe (D). Vector-induced
apoptosis is blocked by coincubation of the infected cells with the caspase-1 inhibitor, YVAD-cmk, indicated by a reduced number of TUNEL-stained cells (F) and
lower-level activation of the ICE-NIRF probe (G). (Panels B–G used  10 magnification.) (H) Quantification of the effect of caspase-1 and caspase-3 inhibitors on
HGC-ICE-lacZ vector – induced activation of the ICE–NIRF probe. Gli36 cells were infected with caspase-1 or control (HGC-Fluc) vectors in the presence or
absence of caspase inhibitors and fluorescence was assessed 24 hours later. Probe signal intensity was normalized to infection efficiency (EGFP signal). The
caspase-1 inhibitor, YVAD-cmk, prevented HGC-ICE-lacZ vector – induced activation of the probe (a two-sample t-test assuming equal variances indicated a
significant difference, P one-tail = .0157, n = 3). The caspase-3 inhibitor, DEVD-fmk, did not significantly affect HGC-ICE-lacZ– induced activation of the probe
(P V .166).
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absence of TUNEL staining, nor did it produce a NIRF
fluorescence signal (data not shown).
The effect of caspase-1 and caspase-3 inhibitors on
HGC-ICE-lacZ–induced activation of the ICE-NIRF probe
by Gli36 cells was quantified by determining the average
intensity of the probe signal across the microscopic field at
633 nm and normalizing that to the average intensity of the
EGFP signal at 488 nm (Figure 2H ). The caspase-1 inhibitor
prevented HGC-ICE-lacZ vector–mediated activation of the
probe. A two-sample t-test assuming equal variances indi-
cated that this difference was significant (P one-tail V .0157,
n = 3). However, there was no significant difference in NIRF
probe activation by HGC-ICE-lacZ in the absence or pres-
ence of the caspase-3 inhibitor (P V .166), and the control
vector did not activate the probe.
ICE-NIRF Probe Detects Apoptosis in Cultured Cells
Several standard methods for inducing apoptosis were
used to determine whether this ICE-NIRF probe could be
used to monitor caspase-1 activity during externally elicited
apoptosis in living cells in culture. One such method for
inducing apoptosis involves treating cells with staurosporine
[43], a microbial alkaloid, which inhibits protein kinases [44].
Treatment of Gli36 glioma cells with 50 mM staurosporine for
24 hours induced apoptosis, as assessed by positive
annexin staining (Figure 3A), and also activated the ICE-
NIRF probe (Figure 3B). Control cells treated with 0.01%
DMSO, the same percentage as in the experimental treat-
ment, did not show significant annexin staining (Figure 3D )
or an ICE-NIRF signal (Figure 3E ). In order to examine
the specific role of caspase-1 in staurosporine-induced
Figure 3. Induction of apoptosis with staurosporine resulting in activation of the ICE-NIRF probe. Gli36 cells were treated with 50 M staurosporine for 24 hours
(A–C) or with the same percentage of DMSO (0.01%) to which experimental wells were exposed (D-488nm laser, E-633nm laser and F-bright field). To examine
the role of caspase-1 in staurosporine-induced apoptosis and probe activation, cells were coincubated in caspase-1 inhibitor (10 M) and staurosporine (G– I).
Staurosporine induces apoptosis, indicated by the positive annexin staining viewed with the 488-nm laser (A), which colocalized with activated probe viewed with
the 633-nm laser (B). Coincubation of the caspase-1 inhibitor with staurosporine did not completely block apoptosis, indicated by the relatively higher number of
apoptotic cells stained with annexin (G), as those that activated the probe (H). Magnification,  40; scale bar, 50 M.
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apoptosis and probe activation, cells were coincubated with
both the caspase-1 inhibitor and staurosporine prior to treat-
ment with probe and annexin (Figure 3G– I ). The caspase-1
inhibitor decreased probe activation (Figure 3H ), but did not
completely block apoptosis (Figure 3G). Thus, a single
caspase inhibitor for caspase-1 was not enough to save the
cells from apoptosis triggered by staurosporine, but did block
activation of the ICE-NIRF probe. Quantification of fluores-
cence intensity indicated that, overall, the caspase-1 inhibitor
reduced staurosporine-induced ICE-NIRF activation by 80%.
Prior studies have demonstrated that C6BVIK glioma
cells stably expressing HSV-TK die in response to treatment
with ganciclovir [38] and that ganciclovir kills by apoptosis
[45]. Viral TK is a prodrug-activating enzyme, which converts
ganciclovir to a toxic nucleoside analogue. First, C6BVIK
cells were treated with concentrations of ganciclovir ranging
from 50 to 150 mg/ml for 7 days and assayed for cell viability
using a WST assay. All concentrations resulted in significant
cell death as compared to their respective controls (P V .01)
with about 40% loss of viability at 150 mg/ml ganciclovir
(Figure 4A). C6BVIK cells treated with ganciclovir for 1 to
7 days were also assessed for apoptosis and probe activa-
tion by staining with annexin and the ICE-NIRF probe.
For time points 3 to 7 days in the presence of ganciclovir
(100 mg/ml), condensed apoptotic nuclei were visible with
4V-6-diamidino-2-phenylindole dihydrochloride (DAPI) or PI
staining (data not shown). C6BVIK cells treated with gan-
ciclovir at 100 mg/ml for 3 days yielded positive annexin
staining (Figure 4B) and ICE-NIRF probe activation (Figure
4C ). Untreated C6BVIK cells did not stain positively for an-
nexin (Figure 4E ) or demonstrate ICE-NIRF fluorescence
(Figure 4F ).
We also examined whether induction of apoptosis by
irradiation of primary neuronal cultures of cerebellar granule
cells would lead to activation of the ICE-NIRF probe. Previ-
ous studies have shown that irradiation of the cerebellum of
newborn mice results in extensive apoptosis in the external
granule layer [46]. Cultured granule cells from newborn mice
were irradiated and, 24 hours later, cultures were incubated
with ICE-NIRF probe and stained with annexin. Positive
annexin staining was observed in irradiated granular cells
(Figure 5A) in parallel with activation of the ICE-NIRF probe
(Figure 5B ). Minimal cellular annexin staining and no detect-
able ICE-NIRF activation were observed in nonirradiated
granule cells (Figure 5, D and E, respectively).
In Vivo Imaging
In an experimental in vivo tumor implant model, Gli36
cells were infected in culture with HGC-ICE-lacZ or HGCX
Figure 4. Treatment of C6BVIK cells expressing HSV-TK with ganciclovir induces apoptosis and activates caspase-1 NIRF probe. (A) C6BVIK cells were treated
with 50 to 150 g/ml ganciclovir and assayed for cell viability using a WST assay. Concentrations of 50, 100, and 150 g/ml ganciclovir resulted in significant cell
death as compared to control treatments (P V .001). (B–G) C6BVIK cells were treated with 100 g/ml ganciclovir for 3 days, prior to being treated with ICE-NIRF
probe and annexin. Treatment with ganciclovir induced apoptosis, assessed by positive annexin staining (B), and activated the ICE-NIRF probe (C). Control
C6BVIK cells not treated with ganciclovir did not stain for annexin (E) or demonstrate ICE-NIRF fluorescence (F). Magnification,  40; scale bar, 50 M.
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virus vectors at an MOI = 1 for 4 hours, which yielded > 95%
infection of cells. Infected cells were implanted bilaterally
(4  106 per site) in the forearms of five nude mice. Twenty-
four hours later, the ICE-NIRF probe was injected i.v. and
the mice imaged 24 hours after probe administration. The
mean pixel intensity of the HGC-ICE-lacZ–infected Gli36
implant was 769.3 AU (SD + 209.2), whereas that of the
HGCX-infected implant was 630.6 AU (SD + 101.0), and the
background in an adjacent area was 436.3 (SD + 77.7). This
background area had low endogenous fluorescence, where-
as nonspecific probe fluorescence was somewhat higher in
the liver, spleen, and bladder, as seen for other NIRF probes
[28]. Subtracting the adjacent background from the implant
values, there was significantly (P V .006) more fluorescence
in HGC-ICE-lacZ– infected cells by 76% than in HGCX-
infected cells. A pseudocolor image of the mean pixel
intensities of NIRF fluorescence minus the background in
implants in one of these mice indicates that this increase in
intensity is visually notable (Figure 6). Of note, the NIRF
fluorescence of the HGCX-infected cell implant was signifi-
cantly (P V .048) higher than the adjacent normal tissue,
suggesting that the vector or injectate volume may have
triggered tissue damage and apoptosis. A direct comparison
of the fluorescence between the HGC-ICE-lacZ–infected
cell implant and adjacent normal tissues indicated a 1.7-fold
increase in mean intensity.
Discussion
Here, we describe the development and characterization of a
caspase-1 (ICE)–specific NIRF probe as a means to non-
invasively image apoptosis in living cells. Specificity was
shown by selective probe activation with caspase-1, and not
caspase-3, and inhibition of activation by a caspase-1 inhib-
itor, and not a caspase-3 inhibitor. Furthermore, induction of
apoptosis and probe activation was demonstrated following
delivery of a caspase-1– lacZ fusion protein to cells in culture
using an HSV amplicon vector. Three different methods
of inducing apoptosis—staurosporine treatment, exposure
of cells expressing HSV-TK to ganciclovir, and irradiation of
cerebellar granule cells—all led to activation of this ICE-
NIRF probe. The caspase-1 inhibitor partially blocked staur-
osporine-induced activation of the probe, but did not
completely block apoptosis, suggesting that staurosporine
induces apoptosis by activating multiple caspase pathways,
some independent of caspase-1, such as activation of the
CED-3 family of proteases [47].
Caspase-1 has been implicated in apoptosis of a num-
ber of cell types. Caspase-1 activity is present in cells
throughout the lifespan of mice and may be an early
mediator of cell death during some types of neuronal
degeneration, with caspase-1 acting as a chronic initiator
and caspase-3 acting as the final executioner of cell death.
Caspase-1–deficient mice show delayed neutrophil apo-
ptosis and a prolonged inflammatory response to lipopoly-
saccharide-induced acute lung injury, but otherwise normal
development and physiology [48]. Caspase-1 is activated
as an early event in the death of motor neurons in
transgenic mouse lines expressing a mutant form of
Cu2+,Zn2+ superoxide dismutase, which develop familial
amyotrophic lateral sclerosis– like disease [20]. In these
animals, activation of caspase-1 is followed by activation of
Figure 5. Induction of apoptosis by irradiation of cerebellar granule cells activates ICE-NIRF probe. Twenty-four hours following irradiation, cultured cells were
incubated with probe and stained with annexin. Positive annexin staining (A) and activation of the ICE-NIRF probe (B) were observed in irradiated granule cells. No
annexin staining or ICE-NIRF probe activation was noted in nonirradiated cultures. Overlays of the fields were observed with the annexin, ICE-NIRF signals, and
brightfield image (C and F). Magnification,  40; scale bar, 50 M.
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caspase-3 and the appearance of apoptotic neurons and
astrocytes specifically in affected regions.
Our laboratory has previously expressed the ICE–lacZ
fusion protein in experimental cancer therapy using a tetra-
cycline-regulated retrovirus vector [49]. In the case of slow-
growing, benign tumors, where reduction in volume can be
therapeutic and the rate of DNA replication may not make
cells susceptible to DNA-damaging agents, delivery of apo-
ptotic proteins, such as ICE–lacZ, may prove efficacious.
Targeting could be achieved by direct injection of vectors
into the tumor mass with consequent volume reduction. In
this context, NIRF imaging could allow direct monitoring of
therapeutic gene expression.
Currently, most ways of studying apoptosis rely on
experiments done on cell extracts in the test tube or
imaging of cells in culture or tissue sections. The former
includes DNA fragmentation or fluorogenic assays using
fluorescently labeled substrates for various caspases, and
the latter includes surface labeling of annexin V, nuclear
staining with PI or TUNEL, or assessment of caspase
activities in intact cells using cell-permeable fluorogenic
caspase substrates. Recently, a fluorescent Cy5.5–
annexin V–NIRF probe has shown promise in imaging
apoptosis in living animals [50]. The key issue in converting
annexin V from a cellular imaging agent to an in vivo
imaging agent was the use of a fluorochrome, which emits
fluorescence light in the near-infrared range. Light in the
NIRF range allows much deeper tissue penetration, as
well as less nonspecific tissue autofluorescence and
reflectance [51].
The potential for imaging of caspase-1 activity in vivo with
the ICE-NIRF probe was evaluated in an experimental tumor
implantation model. Glioma cells were infected in culture with
an HSV amplicon vector encoding caspase-1–lacZ (HGC-
ICE-lacZ) or a control vector, implanted in mice, and evalu-
ated 48 hours later after i.v. ICE-NIRF probe injection. There
was a significant increase (76%) in fluorescence in the ICE–
lacZ vector– infected cells, with a greater increase (171%)
between ICE–lacZ vector– infected cells and adjacent nor-
mal tissue background. The low—but greater than back-
ground—levels of ICE-NIRF fluorescence observed in the
implants infected with control amplicon vector may be due to
apoptosis induced by the vector or injectate. These in vivo
data suggest that this ICE-NIRF probe has the potential to
image caspase-1 activity and apoptosis, depending on en-
zyme levels and tissue depth.
Compared to other methods, imaging apoptosis with an
ICE-NIRF probe has the potential advantage of allowing
much deeper tissue penetration, with less nonspecific tissue
autofluorescence, as compared to imaging using a recom-
binant luciferase reporter molecule and bioluminescence
imaging, as photons do not allow deep tissue penetration
[27]. Furthermore, given the numerous types of caspases
with roles in different biologic processes, it will be highly
advantageous to have probes for in vivo imaging that are
specific to the different caspases. Over the past few years,
we have applied several NIRF protease activatable probes to
various biological systems and have shown great promise
of imaging disease processes through their associated
protease activity [35,52]. The applications include cancer,
Figure 6. Pseudocolor image of caspase-1 activity in vivo. HGC-ICE-lacZ– infected Gli36 cells were implanted into the left side of a nude mouse and HGCX-
infected Gli36 cells into the right side. Animals were imaged 48 hours after injection of cells, 24 hours after tail vein injection of ICE-NIRF probe. The mean pixel
intensity in HGC-ICE-lacZ– infected cells (indicated by white arrow) for this particular animal was 843 AU, as compared to 755 AU for the HGCX-infected cells
(green arrow) and 347 AU for adjacent normal tissue (background). Pseudocolor images represent implant intensities minus the background.
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arteriosclerosis, arthritis, blood coagulation, inflammation,
and others. In conclusion, this novel ICE-NIRF imaging
probe allows high-sensitivity imaging of apoptosis involving
caspase-1 activation in living cells. It should have important
applications in imaging results of therapeutic intervention in
cancer, extent of cell damage in injury models, and normal
apoptotic mechanisms in development.
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